Literature DB >> 22585538

Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous system.

Jana Zdarova Karasova1, Filip Zemek, Kamil Musilek, Kamil Kuca.   

Abstract

The blood-brain barrier plays a vital role in the protection of the central nervous system. It is composed of endothelial cells with tight-junctions to limit the penetration of many endogenous and exogenous compounds, particularly hydrophilic xenobiotics. Nerve agents and pesticides are groups of compounds with high penetration potential into the central nervous system. However, oxime type antidotes are known to penetrate blood-brain barrier only in low concentration. The aim of presented study is to describe the pharmacokinetic profile of oxime K027 a novel antidote candidate. The main focus is on penetration of tested substance into the selected brain regions following time-dependent manner. The maximum concentration of the oxime K027 was attaining 15 and 30 min after i.m. application in plasma and brain tissue, respectively. The perfused brain tissue concentration was relatively high (10(-7) M order of magnitude) and depending on the brain region it was constant 15-60 min after application. The highest concentration was found in the frontal cortex 15 min after application while the lowest measured concentration was determined in the basal ganglia. This study showed that oxime K027 is able to achieve high concentration level in perfused brain tissue relatively quickly, but also demonstrated rapid clearance from the central nervous system. These results are probably due to low overall uptake of oxime K027 into the brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585538     DOI: 10.1007/s12640-012-9329-4

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  25 in total

1.  The blood-brain barrier efflux transporters as a detoxifying system for the brain.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase.

Authors:  Kamil Kuca; Jirí Bielavský; Jirí Cabal; Jirí Kassa
Journal:  Bioorg Med Chem Lett       Date:  2003-10-20       Impact factor: 2.823

3.  Time-related differences in the physical property profiles of oral drugs.

Authors:  Paul D Leeson; Andrew M Davis
Journal:  J Med Chem       Date:  2004-12-02       Impact factor: 7.446

4.  A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.

Authors:  Jiri Kassa; Jana Zdarova Karasova; Filip Caisberger; Kamil Musilek; Kamil Kuca; Young-Sik Jung
Journal:  J Enzyme Inhib Med Chem       Date:  2010-08       Impact factor: 5.051

5.  Pharmacokinetic study of two acetylcholinesterase reactivators, trimedoxime and newly synthesized oxime K027, in rat plasma.

Authors:  Jana Zdarova Karasova; Jaroslav Chladek; Milos Hroch; Fusek Josef; Daniela Hnidkova; Kamil Kuca
Journal:  J Appl Toxicol       Date:  2011-06-30       Impact factor: 3.446

6.  Novel oximes as blood-brain barrier penetrating cholinesterase reactivators.

Authors:  Gregory E Garcia; Amy J Campbell; John Olson; Deborah Moorad-Doctor; Venee I Morthole
Journal:  Chem Biol Interact       Date:  2010-03-12       Impact factor: 5.192

7.  Tabun-inhibited rat tissue and blood cholinesterases and their reactivation with the combination of trimedoxime and HI-6 in vivo.

Authors:  Jiri Bajgar; Jana Zdarova Karasova; Jiri Kassa; Jiri Cabal; Josef Fusek; Vaclav Blaha; Sandra Tesarova
Journal:  Chem Biol Interact       Date:  2010-02-16       Impact factor: 5.192

8.  Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier.

Authors:  Koichi Sakurada; Kazuo Matsubara; Keiko Shimizu; Hiroshi Shiono; Yasuo Seto; Koichiro Tsuge; Mineo Yoshino; Ikuko Sakai; Harutaka Mukoyama; Takehiko Takatori
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

9.  An attempt to assess functionally minimal acetylcholinesterase activity necessary for survival of rats intoxicated with nerve agents.

Authors:  Jiri Bajgar; Josef Fusek; Jiri Kassa; Daniel Jun; Kamil Kuca; Petr Hajek
Journal:  Chem Biol Interact       Date:  2008-05-18       Impact factor: 5.192

Review 10.  Entry of oximes into the brain: a review.

Authors:  D E Lorke; H Kalasz; G A Petroianu; K Tekes
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more
  5 in total

1.  Development of versatile and potent monoquaternary reactivators of acetylcholinesterase.

Authors:  Lukas Gorecki; Vendula Hepnarova; Jana Zdarova Karasova; Martina Hrabinova; Charlotte Courageux; José Dias; Tomas Kucera; Tereza Kobrlova; Lubica Muckova; Lukas Prchal; David Malinak; Daniel Jun; Kamil Musilek; Franz Worek; Florian Nachon; Ondrej Soukup; Jan Korabecny
Journal:  Arch Toxicol       Date:  2021-01-31       Impact factor: 5.153

Review 2.  Recent developments on oximes to improve the blood brain barrier penetration for the treatment of organophosphorus poisoning: a review.

Authors:  Mohd Nor Faiz Norrrahim; Mas Amira Idayu Abdul Razak; Noor Aisyah Ahmad Shah; Herdawati Kasim; Wan Yusmawati Wan Yusoff; Norhana Abdul Halim; Siti Aminah Mohd Nor; Siti Hasnawati Jamal; Keat Khim Ong; Wan Md Zin Wan Yunus; Victor Feizal Knight; Noor Azilah Mohd Kasim
Journal:  RSC Adv       Date:  2020-01-27       Impact factor: 4.036

3.  Small Quaternary Inhibitors K298 and K524: Cholinesterases Inhibition, Absorption, Brain Distribution, and Toxicity.

Authors:  Jana Zdarova Karasova; Milos Hroch; Kamil Musilek; Kamil Kuca
Journal:  Neurotox Res       Date:  2015-12-08       Impact factor: 3.911

Review 4.  The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime.

Authors:  Dietrich E Lorke; Georg A Petroianu
Journal:  Front Neurosci       Date:  2019-05-22       Impact factor: 4.677

5.  Interaction of Cucurbit[7]uril with Oxime K027, Atropine, and Paraoxon: Risky or Advantageous Delivery System?

Authors:  Jana Zdarova Karasova; Martin Mzik; Tomas Kucera; Zbynek Vecera; Jiri Kassa; Vit Sestak
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.